Metabolomic profiling of clinical sputum samples reveals novel biomarkers for the early identification of lung cancer patients

S. Cameron, K. Lewis, M. Beckmann, G. Allison, R. Ghosal, P. Lewis, L. Mur (Aberystwyth, Llanelli, Swansea, United Kingdom)

Source: International Congress 2014 – Improving diagnosis of thoracic tumours
Session: Improving diagnosis of thoracic tumours
Session type: Poster Discussion
Number: 350
Disease area: Thoracic oncology

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Cameron, K. Lewis, M. Beckmann, G. Allison, R. Ghosal, P. Lewis, L. Mur (Aberystwyth, Llanelli, Swansea, United Kingdom). Metabolomic profiling of clinical sputum samples reveals novel biomarkers for the early identification of lung cancer patients. Eur Respir J 2014; 44: Suppl. 58, 350

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Exploiting metabolomic approaches to aid in the diagnosis of lung cancer
Source: International Congress 2016 – Prognostic variables in lung cancer II
Year: 2016

The utility of bronchoscopically acquired tissue for successful lung cancer molecular profiling (LC-MP)
Source: Annual Congress 2013 –Comfort, safety and effectiveness of bronchoscopy
Year: 2013


Large-scale quantitative proteomic analysis identifies pathways in COPD-associated lung cancer
Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers
Year: 2015


Determining genomic rearrangements in clinical lung specimens for assessment of metastatic disease, actionable targets and disease monitoring
Source: International Congress 2016 – New genomic targets in pulmonary disease
Year: 2016


Potential lung cancer biomarkers from bronchoalveolar lavage fluid using metabolomics approaches
Source: International Congress 2016 – Prognostic variables in lung cancer I
Year: 2016


Circulating biomarkers and tumour molecular profiling in patients with non-small cell lung cancer
Source: International Congress 2015 – Biomarkers, immunology and molecular pathology of lung cancer
Year: 2015

Optimization of cfDNA routine use for NSCLC genomic alteration analysis
Source: International Congress 2016 – How the understanding og molecular and genomic crosstalk is helping to diagnose lung disease
Year: 2016


Exploring the 24h-effect of targeted therapies in non-small cell lung cancer from exon array blood profiling using dually constrained correspondence analysis
Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours
Year: 2015

mRNA biomarker screening in pulmonary tumors showing neuroendocrine differentiation
Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer
Year: 2013


Comparative analysis of lung cancer driver mutations from FFPE samples and liquid biopsies by IonTorrent next generation sequencing
Source: International Congress 2016 – Prognostic variables in lung cancer II
Year: 2016


Lung cancer detection by computer assisted analysis of novel biomarkers in induced sputum samples
Source: Annual Congress 2008 - Novel targets in the molecular pathology of lung cancer and COPD
Year: 2008

High-throughput detection of alternative splicing in patients with non-small cell lung cancer treated by bevacizumab/erlotinib
Source: International Congress 2014 – Novel approaches in transcriptomics and epigenomics in inflammatory lung diseases and lung cancer
Year: 2014


Lung cancer biomarkers based on miRNA
Source: Virtual Congress 2021 – Biology of lung cancer: preclinical and translational research
Year: 2021


Dividing EBUS-TBNA samples for simultaneous histopathological and molecular analyses in lung cancer patients
Source: International Congress 2015 – Endoscopic ultrasound: an essential tool for interventional pulmonology
Year: 2015


Potential genetic markers for the early diagnosis of peripheral and metastatic lung cancer
Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers
Year: 2015


High-throughput molecular analysis in lung cancer: insights into biology and potential clinical applications
Source: Eur Respir J 2009; 33: 489-506
Year: 2009



Metabolomic analysis of serum samples from patients with lung cancer
Source: International Congress 2014 – Biology and pathology of thoracic tumours
Year: 2014


The Liverpool Lung Project: a molecular epidemiological study of early lung cancer detection
Source: Eur Respir J 2002; 20: 464-479
Year: 2002



Early detection of lung cancer in exhaled breath condensate using miRNA markers
Source: International Congress 2015 – Developments in lung cancer diagnosis
Year: 2015